Study touts use of FDG-PET in treating Peutz-Jeghers syndrome

06/18/2009 | AuntMinnie.com (free registration)

Researchers used FDG-PET to monitor the effectivity of a class of drugs called rapamycin analogs in treating Peutz-Jeghers syndrome, a rare genetic disease that increases a patient's risk of colon cancer. Polyps in mice were found to have a high FDG uptake, suggesting that the drug could be used in the future to control lesion growth, and that "FDG-PET may find clinical utility for the identification of polyps in [Peutz-Jeghers syndrome] patients," the researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD